Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis
This study is conducted to:
- Investigate the effect of virtual reality based training on balance and risk of falling.
- Investigate the effect of virtual reality based training on gait.
- Investigate the effect of mental practice on balance and risk of falling.
- Investigate the effect of mental practice on gait.
- Compare between the effect of virtual reality based training and mental practice on balance and gait
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Background: Multiple sclerosis affects the central integration of sensory afferents that causes disturbance of balance, postural control and gait. Exercise interventions performed through VR applications encourage participants to engage in challenging tasks that integrate motor and cognitive demands, enhance patients' sensory processing and integration systems and allows them to receive information feedback and improve the motivation of training. Mental Practice is a complex cognitive operation that is possible thanks to the use of sensory and perceptive processes that allow an individual to reactivate specific motor actions in the working memory.
Purpose: This study is conducted to Investigate the effect of virtual reality based training on balance and risk of falling, Investigate the effect of virtual reality based training on gait, Investigate the effect of mental practice on balance and risk of falling, Investigate the effect of mental practice on gait and to compare between the effect of virtual reality based training and mental practice on balance and gait.
Methods: Fifty four patients of both sexes with relapsing remitting MS (RRMS). The patients will be diagnosed as having RRMS based on careful clinical examination by neurologist and diagnosis will be confirmed by radiological investigations as magnetic resonance imaging (MRI). Patients will be recruited from the outpatient clinic of Faculty of Physical Therapy, Pharos University in Alexandria and private clinics. Patients in this study will be randomly divided into three groups.
- Group (I) which will include 18 patients who will receive mental practice in addition to selected physical therapy .
- Group (II) which will include 18 patients who will receive virtual reality based training in addition to selected physical therapy.
- Group (III) which will include 18 patients who will receive selected physical therapy.
The treatment will be conducted 3 sessions per week for 6 weeks for 45 minutes.
Results: Data analysis with 2-way mixed Design MANOVA will be used to compare the groups for normally distributed data and Kruskal Wallis and Mann-Whitney tests will be used to compare the groups for non-parametric and not normally distributed data.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Ola Z Asal, BSc
- Número de teléfono: 00201023830508
- Correo electrónico: ola25jan@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Nagwa I Rehab, PhD
- Número de teléfono: 00201008124920
- Correo electrónico: Nagwa1102010@yahoo.com
Ubicaciones de estudio
-
-
Giza Governorate
-
Giza, Giza Governorate, Egipto
- Reclutamiento
- Faculty of Physical Therapy, Cairo University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients with RRMS.
- Patient's age will be range from 20 - 35 years..
- Patients are able to walk 10 meter with or without assistance.
- Patients with ≤ 6 according to an Expanded Disability Status Scale (EDSS).
- Patients are cognitively able to follow instructions.
- Patient's body mass index (BMI) will be ranged from 18.5 to 29.99 Kg/m2.
Exclusion Criteria:
- Patients with MS relapse in the last 30 days.
- Visual impairments interfering with VR.
- Severe spasticity or orthopaedic deformity.
- Recent musculoskeletal injury.
- History of epilepsy or motion sickness with VR.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Realidad virtual
|
The virtual environment presented via Head Mounted Display (HMD) has three-dimensional presentation and the panoramic view that covers the users' field of view, it facilitates immersion in the virtual and distraction from the real world |
|
Experimental: Mental Practice
|
Mental Practice is among the recommended strategies to enhance performance. MP is a symbolic exercise, involving repeated mental imagery in the absence of any visible muscle contraction. |
|
Experimental: Selected Physical Therapy Program
|
Dual tasking and Task oriented training in static and dynamic forms |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Gait
Periodo de tiempo: 6 weeks
|
spatial, temporal and angular parameters as cadence, step length and range of motion of hip, knee and ankle will be measured using software analysis "Kinovea" Kinovea is a free, open-source 2D video analysis software. It does not generate a single composite "score". Instead, it measures quantitative biomechanical and kinematic metrics from recorded video. |
6 weeks
|
|
Gait
Periodo de tiempo: 6 weeks
|
"10 minutes walk test" will be performed pre and post treatment by asking the patient to walk through a 12 meter walkway and calculate the time for 10 meters in tha walkway in two walking speeds( normal - fast) for 2 or 3 trials of each speed Speed > 1.2 m/s: Normal / Community AmbulatorAble to safely cross street intersections and navigate crowded environments. 0.8 - 1.2 m/s: Limited Community Ambulator/ Able to walk outdoors independently 0.4 - 0.8 m/s: Household Ambulator/ Mostly restricted to indoor walking; requires assistance or equipment outdoors. < 0.4 m/s: Severe Functional Limitation |
6 weeks
|
|
Balance
Periodo de tiempo: 6 weeks
|
static and dynamic balance will be assessed using "Berg Balance Scale" The Berg Balance Scale (BBS) is a 14-item clinical assessment scale designed to measure static balance and dynamic functional mobility, Point Scale: Each of the 14 tasks is rated on a 0 to 4 ordinal scale based on safety, independence, time held, or distance reached, Scores are summed across all items for a overall score ranging from 0 to 56 points (higher scores reflect better balance and mobility). |
6 weeks
|
|
Balance
Periodo de tiempo: 6 weeks
|
"Timed Up and Go" test giving numerical data pre and post treatment about balance and risk of falling Test is scored entirely by time (in seconds): Time < 10 seconds: Normal / Completely IndependentFreely mobile; minimal to no fall risk 10 - 19 seconds: Mostly Independent, Reasonable balance and gait speed, generally low fall risk 20 - 29 seconds: Variable MobilityImpaired mobility, slower gait speed > 30 seconds: Severely Impaired, high fall risk |
6 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Nagwa I Rehab, PhD, Cairo University
- Director de estudio: Rania M Tawfik, PhD, Cairo University
- Director de estudio: Ebtesam M Fahmy, PhD, Cairo University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- P.T.REC/012/006172
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .